McKesson Reports Q4 and Full-Year Fiscal 2026 Earnings
McKesson (MCK) reported strong fiscal year earnings with adjusted EPS of $39.11, up 18%, driven by broad-based demand and operational improvements. The company guided to a 12%-14% increase in FY 2027 EPS. Consolidated revenues reached $403 billion for the year.
Tickers: $MCK
Topics: operating_profit pharmaceuticals revenue_growth segment_performance